WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Stock Falls 8.8% – Here’s What Happened

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was down 8.8% during mid-day trading on Thursday. The stock traded as low as $13.49 and last traded at $13.49. 30,944 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 71,118 shares. The stock had previously closed at $14.79.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, WuXi Biologics (Cayman) has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Stock Up 0.1%

The firm’s fifty day moving average is $12.67 and its two-hundred day moving average is $10.13.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.